MK-0663 Type of group

A MULTICENTER, RANDOMIZED, PARALLEL-GROUP, ACTIVE- AND PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY CONDUCTED UNDER IN-HOUSE BLINDING CONDITIONS TO DETERMINE THE INCIDENCE OF GASTRODUODENAL ULCERS IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER 12 WEEKS OF TREATMENT WITH MK-0663, NAPROXEN, OR PLACBO

DOUBLE-BLIND STUDY MULTICENTRIC RANDOMIZED BY PARALLEL GROUPS CONTROLLED BY PLACEBO AND ACTIVE COMPARATOR CONDUCTED UNDER BLIND INTERNAL CONDITIONS TO DETERMINE THE INCIDENCE OF GASTRODUODENAL ULCERAS IN PATIENTS WITH OSTEOARTHRITIS AFTER 12 TREATMENT WITH MK-0663, IBUPROFENO OR PLACEBO

A 6-WEEK DOUBLE-BLIND STUDY CONTROLLED BY MULTICENTRIC PLACEBO TO EVALUATE THE SAFETY AND EFFECTIVENESS OF MK-0663 IN THE TREATMENT OF HEMOPHILIA ARTHROPATHY